Cornercap Investment Counsel Inc Aldeyra Therapeutics, Inc. Transaction History
Cornercap Investment Counsel Inc
- $637 Million
- Q1 2024
A detailed history of Cornercap Investment Counsel Inc transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Cornercap Investment Counsel Inc holds 61,601 shares of ALDX stock, worth $197,123. This represents 0.03% of its overall portfolio holdings.
Number of Shares
61,601
Previous 61,601
-0.0%
Holding current value
$197,123
Previous $216,000
6.94%
% of portfolio
0.03%
Previous 0.04%
Shares
1 transactions
Others Institutions Holding ALDX
# of Institutions
106Shares Held
35.4MCall Options Held
104KPut Options Held
88.1K-
Perceptive Advisors LLC New York, NY8.59MShares$27.5 Million0.59% of portfolio
-
Knoll Capital Management, LLC Miami, FL5.48MShares$17.5 Million11.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.87MShares$12.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.31MShares$10.6 Million0.0% of portfolio
-
Kennedy Capital Management, Inc. St Louis, MO1.32MShares$4.22 Million0.09% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $187M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...